Neuro-cognitive Function 1 Year Post ICU Discharge Among VV ECMO Survivors

Status Not yet recruiting

Clinical Trial Summary

In the past three years, in the general intensive care unit in Meir medical center, 25 patients were treated with ECMO, of which two patients were treated with VA ECMO and the rest with VV ECMO. 70% of the patients survived to hospital discharge. ECMO is indicated as a rescue therapy for patients in critical condition suffering from severe cardiac and/or respiratory failure that does not respond to conservative treatment. It can be used as a bridge to recovery or to heart/lung transplantation. ECMO was introduced in the late seventies of the pervious century. Between the years 2006-2011, partly due to the outbreak of the flu epidemic (H1N1), a 433% increase was observed in the use of ECMO worldwide in adults. In light of the outbreak of the Covid-19 epidemic in recent years, another significant increase has been observed. There are short-term and long-term complications of ECMO. Short-term complications include bleeding, thrombosis, hemolysis, HIT, renal and neurological injuries, associated infections, and technical-mechanical problems. Long-term complications include significant physical and psychological consequences that may adversely affect the patient's daily function, especially executive function.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06224088
Study type	Observational
Source	Meir Medical Center
Contact
Status	Not yet recruiting
Phase
Start date	March 1, 2024
Completion date	February 1, 2028

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04005456` - Personalized Lifestyle Intervention for Improving Functional Health Outcomes Using N-of-1 Tent-Umbrella-Bucket Design	N/A
Enrolling by invitation	`NCT06227962` - Cognitive Functioning and Health Related Quality of Life in Retinoblastoma Survivors
Completed	`NCT04038788` - Add-on HD Hf-tRNS Over Bilateral DLPFC for Treating Patients With Schizophrenia	N/A
Withdrawn	`NCT01186289` - Statin Therapy To Limit Cognitive Dysfunction After Cardiac Surgery	N/A
Recruiting	`NCT05077748` - An 18-year Follow-up Study on OSA in a Population-based Cohort
Recruiting	`NCT03606421` - CBF and NCF Changes With Brain Radiation
Recruiting	`NCT03709199` - Long Term Follow up of Children Enrolled in the REDvent Study
Recruiting	`NCT04458207` - Cognitive Changes and Neural Correlates After Rehabilitation of Masticatory Function in Elderly -an Intervention Study	N/A
Recruiting	`NCT05363332` - Impact and Sequelae of High Ventilatory Drive in Critically Ill COVID-19 Patients
Recruiting	`NCT03886675` - Intervention With Cerebral Embolic Protection in TEVAR: Gaseous Protection	N/A
Enrolling by invitation	`NCT04373525` - Prospective Evaluation on Cognitive Function and Its Associated Genetic Vulnerability in Cannabis Users
Enrolling by invitation	`NCT04881266` - Long-Term Functional, Quality-of-Life, Neuropsychological and Cognitive Outcomes in COVID-19 Critical Illness Survivors
Completed	`NCT03795454` - Can Singing Kangaroo Improve Outcome of Preterm Infants	N/A
Recruiting	`NCT05019300` - Long-term Neurocognitive and Psychiatric Consequences in Severe COVID-19 Survivors.
Not yet recruiting	`NCT05245903` - Passive Sensor Identification of Digital Biomarkers to Assess Effects of Orally Administered Nicotinamide Riboside
Terminated	`NCT03163277` - Using Less Neurotoxic Drugs in Patients With HAND (MARAND-X)	Phase 4
Completed	`NCT03460821` - Validation of a German Translation and Cultural Adaptation of the Addenbrooke's Cognitive Examination III
Not yet recruiting	`NCT06413173` - Remotely Supervised tDCS+ for Complex Attention in mTBI (Cognetric)	N/A
Terminated	`NCT03863639` - Changes in fMRI and Neurocognitive Function in Women With Pre-eclampsia
Enrolling by invitation	`NCT03567304` - Neurocognitive Function Improvement After Switching From Efavirenz to Rilpivirine	Phase 4